MediciNova Inc (MNOV)
1.34
-0.05
(-3.60%)
USD |
NASDAQ |
Apr 22, 16:00
1.36
+0.02
(+1.49%)
After-Hours: 20:00
MediciNova Enterprise Value: 14.72M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 14.72M |
| April 19, 2024 | 17.17M |
| April 18, 2024 | 17.67M |
| April 17, 2024 | 19.14M |
| April 16, 2024 | 23.55M |
| April 15, 2024 | 24.53M |
| April 12, 2024 | 26.00M |
| April 11, 2024 | 25.51M |
| April 10, 2024 | 23.55M |
| April 09, 2024 | 22.08M |
| April 08, 2024 | 22.08M |
| April 05, 2024 | 22.08M |
| April 04, 2024 | 20.61M |
| April 03, 2024 | 23.55M |
| April 02, 2024 | 22.08M |
| April 01, 2024 | 21.10M |
| March 28, 2024 | 20.12M |
| March 27, 2024 | 21.10M |
| March 26, 2024 | 15.70M |
| March 25, 2024 | 16.68M |
| March 22, 2024 | 17.17M |
| March 21, 2024 | 18.65M |
| March 20, 2024 | 16.68M |
| March 19, 2024 | 13.74M |
| March 18, 2024 | 15.21M |
| Date | Value |
|---|---|
| March 15, 2024 | 12.76M |
| March 14, 2024 | 15.70M |
| March 13, 2024 | 15.21M |
| March 12, 2024 | 17.67M |
| March 11, 2024 | 16.68M |
| March 08, 2024 | 17.67M |
| March 07, 2024 | 14.23M |
| March 06, 2024 | 16.68M |
| March 05, 2024 | 18.16M |
| March 04, 2024 | 16.68M |
| March 01, 2024 | 15.21M |
| February 29, 2024 | 15.21M |
| February 28, 2024 | 15.70M |
| February 27, 2024 | 12.27M |
| February 26, 2024 | 12.76M |
| February 23, 2024 | 11.78M |
| February 22, 2024 | 14.23M |
| February 21, 2024 | 15.21M |
| February 20, 2024 | 16.19M |
| February 16, 2024 | 15.70M |
| February 15, 2024 | 15.21M |
| February 14, 2024 | 16.68M |
| February 13, 2024 | 15.21M |
| February 12, 2024 | 15.70M |
| February 09, 2024 | 18.40M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.78M
Minimum
Feb 23 2024
506.06M
Maximum
May 16 2019
131.14M
Average
94.05M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.139M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 16.07M |
| Theriva Biologics Inc | -13.17M |
| Oragenics Inc | 3.172M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.059M |
| Total Expenses (Quarterly) | 2.490M |
| EPS Diluted (Quarterly) | -0.04 |
| Earnings Yield | -12.69% |
| Normalized Earnings Yield | -14.18 |